ArticleEye (London, England)2025

Brolucizumab clinical and safety outcomes in a neovascular age-related macular degeneration national database: Fight Retinal Blindness Spain (FRB Spain).

Javier Zarranz-Ventura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.